- Home
- ACET vs LVO Comparison
ACET vs LVO Comparison
Compare ACET & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- LVO
- Stock Information
- Founded
- ACET 1947
- LVO 2009
- Country
- ACET United States
- LVO United States
- Employees
- ACET N/A
- LVO N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- LVO Restaurants
- Sector
- ACET Health Care
- LVO Consumer Discretionary
- Exchange
- ACET Nasdaq
- LVO Nasdaq
- Market Cap
- ACET 70.3M
- LVO 79.4M
- IPO Year
- ACET N/A
- LVO N/A
- Fundamental
- Price
- ACET $0.67
- LVO $0.62
- Analyst Decision
- ACET Buy
- LVO Strong Buy
- Analyst Count
- ACET 6
- LVO 2
- Target Price
- ACET $6.00
- LVO $2.75
- AVG Volume (30 Days)
- ACET 312.0K
- LVO 294.1K
- Earning Date
- ACET 03-06-2025
- LVO 02-13-2025
- Dividend Yield
- ACET N/A
- LVO N/A
- EPS Growth
- ACET N/A
- LVO N/A
- EPS
- ACET N/A
- LVO N/A
- Revenue
- ACET N/A
- LVO $126,016,000.00
- Revenue This Year
- ACET N/A
- LVO $0.69
- Revenue Next Year
- ACET N/A
- LVO N/A
- P/E Ratio
- ACET N/A
- LVO N/A
- Revenue Growth
- ACET N/A
- LVO 11.43
- 52 Week Low
- ACET $0.67
- LVO $0.56
- 52 Week High
- ACET $2.40
- LVO $1.99
- Technical
- Relative Strength Index (RSI)
- ACET 32.94
- LVO 34.69
- Support Level
- ACET $0.74
- LVO $0.67
- Resistance Level
- ACET $0.91
- LVO $0.86
- Average True Range (ATR)
- ACET 0.06
- LVO 0.07
- MACD
- ACET -0.01
- LVO -0.00
- Stochastic Oscillator
- ACET 0.36
- LVO 1.29
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.